Assetmark, Inc Biotechnology

Assetmark, Inc

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
TGTX Tg Therapeutics, Inc.	$6B	$2,000 0.0% of portfolio	91	Q3 2024 New
BPMC Blueprint Medicines Corp	$5.24B	$1,000 0.0% of portfolio	14	Q4 2024 Added 133.33%
GERN Geron Corp	$537M	$1,000 0.0% of portfolio	335	Q4 2019 Reduced 19.28%
HRMY Harmony Biosciences Holdings, Inc.	$1.75B	$1,000 0.0% of portfolio	37	Q4 2024 Added 15.63%
IONS Ionis Pharmaceuticals Inc	$4.22B	$1,000 0.0% of portfolio	32	Q4 2024 New
ACAD Acadia Pharmaceuticals Inc	$2.38B	$0 0.0% of portfolio	37	Q4 2024 New
APLS Apellis Pharmaceuticals, Inc.	$1.92B	$0 0.0% of portfolio	31	Q4 2024 Reduced 99.93%
ACLX Arcellx, Inc.	$2.79B	$0 0.0% of portfolio	10	Q4 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.4B	$0 0.0% of portfolio	6	Q4 2024 New
CRSP Crispr Therapeutics Ag	$2.99B	$0 0.0% of portfolio	15	Q4 2024 New
CYTK Cytokinetics Inc	$3.81B	$0 0.0% of portfolio	10	Q4 2024 New
GBIO Generation Bio Co.	$25.4M	$0 0.0% of portfolio	100	Q4 2024 New
KRYS Krystal Biotech, Inc.	$4.31B	$0 0.0% of portfolio	1	Q4 2024 New
NUVL Nuvalent, Inc.	$3.16B	$0 0.0% of portfolio	1	Q4 2024 New
RVMD Revolution Medicines, Inc.	$3.4B	$0 0.0% of portfolio	12	Q4 2024 Added 500.0%
RARE Ultragenyx Pharmaceutical Inc.	$2.67B	$0 0.0% of portfolio	6	Q4 2024 New
WVE Wave Life Sciences Ltd.	$575M	$0 0.0% of portfolio	54	Q4 2024 New

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.